Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphomaVadim Ivanov, Régis Costello, Cédric Mercier et al.|Leukemia & lymphoma/Leukemia and lymphoma|2020Cited by 0